Professional Documents
Culture Documents
Scott D. Solomon, MD
Professor of Medicine
Harvard Medical School
Director, Noninvasive Cardiology
Director, Cardiac Imaging Core
Laboratory and Clinical Trials
Endpoints Center
Brigham and Womens Hospital
Boston, Massachusetts
Panelists
Philip B. Adamson, MD
Director, Heart Failure Institute
Oklahoma Heart Hospital
Director, Oklahoma Foundation for
Cardiovascular Research
Adjunct Associate Professor of Physiology
University of Oklahoma Health Sciences
Center
Oklahoma City, Oklahoma
Paul Hauptman, MD
Professor of Internal Medicine
Division of Cardiology
Assistant Dean, Clinical and Translational
Research
Saint Louis University School of Medicine
St. Louis, Missouri
Learning Objectives
Identify persistent treatment gaps for
people with HF
Evaluate potential mechanisms
underlying the risk for SCD and HF
Assess the role of ICDs and WCDs to
address the risk of SCD in patients
with ischemic and nonischemic HF
Breakdown of Sudden
Unexpected Death by
Other CV death
N=
Autopsy
Results
VALIANT
2% in
Non-CV
death
105
Pump failure
4%
3%
Myocardial ruptures
12%
Presumed
arrhythmic death
(n = 52)
49%
Myocardial infarction
30%
3% of index MI
27% of
recurrent MI
Cause of Death
Type of Death
DINAMIT (n = 342)
Sudden, presumed
arrhythmic
29 (54%)
Cardiac, nonarrhythmic
17 (31%)
Noncardiac
8 (15%)
Total
54 (16%)
Dorian D, et al.[3]
Types of Arrhythmias
2% to 5% are probably
unrecoverable
85% to 90% are
tachyarrhythmias
Electromechanical disassociation
PEA-type
Sustained bradyarrhythmias
account for maybe 10%